New York: 01:31 || London: 06:31 || Mumbai: 12:01 || Singapore: 14:31

News & Analysis » Europe

Basilea Pharma H1 Loss Narrows - Quick Facts

August 19, 2010, Thursday, 13:28 GMT | 08:28 EST | 17:58 IST | 20:28 SGT

(RTTNews) - Basilea Pharmaceutica AG (BPMUF.PK) reported that its first-half net loss narrowed to CHF 24.9 million from CHF 66.5 million in the prior year. Loss per share was CHF 2.60, narrower than CHF 6.95 a year earlier.

Revenues and other income rose to CHF 53.1 million from CHF 12.2 million in the previous year. Contract revenue increased to CHF 39.1 million from CHF 4.2 million a year ago.